These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7739001)

  • 1. Measuring diversity: experimental design of combinatorial libraries for drug discovery.
    Martin EJ; Blaney JM; Siani MA; Spellmeyer DC; Wong AK; Moos WH
    J Med Chem; 1995 Apr; 38(9):1431-6. PubMed ID: 7739001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DIVSEL and COMPLIB--strategies for the design and comparison of combinatorial libraries using pharmacophoric descriptors.
    Pickett SD; Luttmann C; Guerin V; Laoui A; James E
    J Chem Inf Comput Sci; 1998; 38(2):144-50. PubMed ID: 9538516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond mere diversity: tailoring combinatorial libraries for drug discovery.
    Martin EJ; Critchlow RE
    J Comb Chem; 1999 Jan; 1(1):32-45. PubMed ID: 10746013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors.
    Matter H
    J Med Chem; 1997 Apr; 40(8):1219-29. PubMed ID: 9111296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New methodology for profiling combinatorial libraries and screening sets: cleaning up the design process with HARPick.
    Good AC; Lewis RA
    J Med Chem; 1997 Nov; 40(24):3926-36. PubMed ID: 9397173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for combinatorial and parallel library design.
    Schnur DM; Beno BR; Tebben AJ; Cavallaro C
    Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design of combinatorial libraries using properties and 3D pharmacophore fingerprints.
    Beno BR; Mason JS
    Drug Discov Today; 2001 Mar; 6(5):251-258. PubMed ID: 11182598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of focused chemical libraries using recursive partitioning.
    Rusinko A; Young SS; Drewry DH; Gerritz SW
    Comb Chem High Throughput Screen; 2002 Mar; 5(2):125-33. PubMed ID: 11966421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current directions in the evolution of compound libraries.
    Webb TR
    Curr Opin Drug Discov Devel; 2005 May; 8(3):303-8. PubMed ID: 15892244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity measures for enhancing ADME admissibility of combinatorial libraries.
    Darvas F; Dormán G; Papp A
    J Chem Inf Comput Sci; 2000; 40(2):314-22. PubMed ID: 10761133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug design: combinatorial chemistry and molecular modeling.
    Kirkpatrick DL; Watson S; Ulhaq S
    Comb Chem High Throughput Screen; 1999 Aug; 2(4):211-21. PubMed ID: 10469881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased diversity of libraries from libraries: chemoinformatic analysis of bis-diazacyclic libraries.
    López-Vallejo F; Nefzi A; Bender A; Owen JR; Nabney IT; Houghten RA; Medina-Franco JL
    Chem Biol Drug Des; 2011 May; 77(5):328-42. PubMed ID: 21294850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.
    Franzini RM; Neri D; Scheuermann J
    Acc Chem Res; 2014 Apr; 47(4):1247-55. PubMed ID: 24673190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of diversity and focused combinatorial libraries in drug discovery.
    Young SS; Ge N
    Curr Opin Drug Discov Devel; 2004 May; 7(3):318-24. PubMed ID: 15216935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
    Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
    J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of combinatorial library methods in cancer research and drug discovery.
    Lam KS
    Anticancer Drug Des; 1997 Apr; 12(3):145-67. PubMed ID: 9154108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR structural characterization of oligo-N-substituted glycine lead compounds from a combinatorial library.
    Bradley EK; Kerr JM; Richter LS; Figliozzi GM; Goff DA; Zuckermann RN; Spellmeyer DC; Blaney JM
    Mol Divers; 1997; 3(1):1-15. PubMed ID: 9527473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-assisted combinatorial chemistry: thermodynamics and kinetics in drug discovery.
    Cheeseman JD; Corbett AD; Gleason JL; Kazlauskas RJ
    Chemistry; 2005 Mar; 11(6):1708-16. PubMed ID: 15565741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.